These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17052657)

  • 1. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data.
    Fung HC; Scholz S; Matarin M; Simón-Sánchez J; Hernandez D; Britton A; Gibbs JR; Langefeld C; Stiegert ML; Schymick J; Okun MS; Mandel RJ; Fernandez HH; Foote KD; Rodríguez RL; Peckham E; De Vrieze FW; Gwinn-Hardy K; Hardy JA; Singleton A
    Lancet Neurol; 2006 Nov; 5(11):911-6. PubMed ID: 17052657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data.
    Schymick JC; Scholz SW; Fung HC; Britton A; Arepalli S; Gibbs JR; Lombardo F; Matarin M; Kasperaviciute D; Hernandez DG; Crews C; Bruijn L; Rothstein J; Mora G; Restagno G; Chiò A; Singleton A; Hardy J; Traynor BJ
    Lancet Neurol; 2007 Apr; 6(4):322-8. PubMed ID: 17362836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release.
    Matarín M; Brown WM; Scholz S; Simón-Sánchez J; Fung HC; Hernandez D; Gibbs JR; De Vrieze FW; Crews C; Britton A; Langefeld CD; Brott TG; Brown RD; Worrall BB; Frankel M; Silliman S; Case LD; Singleton A; Hardy JA; Rich SS; Meschia JF
    Lancet Neurol; 2007 May; 6(5):414-20. PubMed ID: 17434096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
    Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
    Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study.
    Elbaz A; Nelson LM; Payami H; Ioannidis JP; Fiske BK; Annesi G; Carmine Belin A; Factor SA; Ferrarese C; Hadjigeorgiou GM; Higgins DS; Kawakami H; Krüger R; Marder KS; Mayeux RP; Mellick GD; Nutt JG; Ritz B; Samii A; Tanner CM; Van Broeckhoven C; Van Den Eeden SK; Wirdefeldt K; Zabetian CP; Dehem M; Montimurro JS; Southwick A; Myers RM; Trikalinos TA
    Lancet Neurol; 2006 Nov; 5(11):917-23. PubMed ID: 17052658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.
    Liu X; Cheng R; Verbitsky M; Kisselev S; Browne A; Mejia-Sanatana H; Louis ED; Cote LJ; Andrews H; Waters C; Ford B; Frucht S; Fahn S; Marder K; Clark LN; Lee JH
    BMC Med Genet; 2011 Aug; 12():104. PubMed ID: 21812969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association mapping of the PARK10 region for Parkinson's disease susceptibility genes.
    Wan JY; Edwards KL; Hutter CM; Mata IF; Samii A; Roberts JW; Agarwal P; Checkoway H; Farin FM; Yearout D; Zabetian CP
    Parkinsonism Relat Disord; 2014 Jan; 20(1):93-8. PubMed ID: 24156912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study.
    von Otter M; Bergström P; Quattrone A; De Marco EV; Annesi G; Söderkvist P; Wettinger SB; Drozdzik M; Bialecka M; Nissbrandt H; Klein C; Nilsson M; Hammarsten O; Nilsson S; Zetterberg H
    BMC Med Genet; 2014 Dec; 15():131. PubMed ID: 25496089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study.
    Quadri M; Mandemakers W; Grochowska MM; Masius R; Geut H; Fabrizio E; Breedveld GJ; Kuipers D; Minneboo M; Vergouw LJM; Carreras Mascaro A; Yonova-Doing E; Simons E; Zhao T; Di Fonzo AB; Chang HC; Parchi P; Melis M; Correia Guedes L; Criscuolo C; Thomas A; Brouwer RWW; Heijsman D; Ingrassia AMT; Calandra Buonaura G; Rood JP; Capellari S; Rozemuller AJ; Sarchioto M; Fen Chien H; Vanacore N; Olgiati S; Wu-Chou YH; Yeh TH; Boon AJW; Hoogers SE; Ghazvini M; IJpma AS; van IJcken WFJ; Onofrj M; Barone P; Nicholl DJ; Puschmann A; De Mari M; Kievit AJ; Barbosa E; De Michele G; Majoor-Krakauer D; van Swieten JC; de Jong FJ; Ferreira JJ; Cossu G; Lu CS; Meco G; Cortelli P; van de Berg WDJ; Bonifati V;
    Lancet Neurol; 2018 Jul; 17(7):597-608. PubMed ID: 29887161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease.
    Mata IF; Yearout D; Alvarez V; Coto E; de Mena L; Ribacoba R; Lorenzo-Betancor O; Samaranch L; Pastor P; Cervantes S; Infante J; Garcia-Gorostiaga I; Sierra M; Combarros O; Snapinn KW; Edwards KL; Zabetian CP
    Mov Disord; 2011 Apr; 26(5):819-23. PubMed ID: 21425343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
    Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional variant rs17525453 within RAB35 gene promoter is possibly associated with increased risk of Parkinson's disease in Taiwanese population.
    Wang HL; Yeh TH; Huang YZ; Weng YH; Chen RS; Lu CS; Wei KC; Liu YC; Chen YL; Chen CL; Chen YJ; Lin YW; Hsu CC; Chiu CH; Chiu CC
    Neurobiol Aging; 2021 Nov; 107():189-196. PubMed ID: 34275689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further delineation of the association signal on chromosome 5 from the first whole genome association study in Parkinson's disease.
    Sharma M; Lichtner P; Kruger R; Berg D; Schulte C; Illig T; Riess O; Gasser T
    Neurobiol Aging; 2009 Oct; 30(10):1706-9. PubMed ID: 18280617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
    Berge-Seidl V; Pihlstrøm L; Maple-Grødem J; Forsgren L; Linder J; Larsen JP; Tysnes OB; Toft M
    Neurosci Lett; 2017 Sep; 658():48-52. PubMed ID: 28830825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic association study of synphilin-1 in idiopathic Parkinson's disease.
    Myhre R; Klungland H; Farrer MJ; Aasly JO
    BMC Med Genet; 2008 Mar; 9():19. PubMed ID: 18366718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.
    Chung SJ; Jung Y; Hong M; Kim MJ; You S; Kim YJ; Kim J; Song K
    Neurobiol Aging; 2013 Nov; 34(11):2695.e1-7. PubMed ID: 23820587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of imaging genetics analysis to explain degree of depression in Parkinson's disease.
    Won JH; Kim M; Park BY; Youn J; Park H
    PLoS One; 2019; 14(2):e0211699. PubMed ID: 30742647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations.
    Rudakou U; Yu E; Krohn L; Ruskey JA; Asayesh F; Dauvilliers Y; Spiegelman D; Greenbaum L; Fahn S; Waters CH; Dupré N; Rouleau GA; Hassin-Baer S; Fon EA; Alcalay RN; Gan-Or Z
    Brain; 2021 Mar; 144(2):462-472. PubMed ID: 33349842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson's disease in a Swedish population.
    Shahabi HN; Westberg L; Melke J; Håkansson A; Belin AC; Sydow O; Olson L; Holmberg B; Nissbrandt H
    J Neural Transm (Vienna); 2009 May; 116(5):567-73. PubMed ID: 19381774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARK16 polymorphisms, interaction with smoking, and sporadic Parkinson's disease in Japan.
    Miyake Y; Tanaka K; Fukushima W; Kiyohara C; Sasaki S; Tsuboi Y; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M; Nakamura Y;
    J Neurol Sci; 2016 Mar; 362():47-52. PubMed ID: 26944116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.